Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system agents and receptor modulators. Its fluorinated benzyl structure enhances binding affinity and metabolic stability in drug candidates. Commonly employed in the preparation of experimental compounds targeting neurological disorders, including potential applications in antidepressant and antipsychotic research. Also utilized in the design of novel kinase inhibitors and other bioactive molecules where fluorine substitution improves pharmacokinetic properties.